These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 567550)

  • 1. Kinetics of norethindrone in women. I. Radioimmunoassay and concentrations during multiple dosing.
    Back DJ; Breckenridge AM; Crawford FE; Mciver M; Orme ML; Park BK; Rowe PH; Smith E
    Clin Pharmacol Ther; 1978 Oct; 24(4):439-47. PubMed ID: 567550
    [No Abstract]   [Full Text] [Related]  

  • 2. Kinetics of norethindrone in women. II. Single-dose kinetics.
    Back DJ; Breckenridge AM; Crawford FE; Mciver M; Orme ML; Rowe PH; Smith E
    Clin Pharmacol Ther; 1978 Oct; 24(4):448-53. PubMed ID: 688734
    [No Abstract]   [Full Text] [Related]  

  • 3. Plasma levels of norethindrone after single oral dose administration of norethindrone and lynestrenol.
    Odlind V; Weiner E; Victor A; Johansson ED
    Clin Endocrinol (Oxf); 1979 Jan; 10(1):29-38. PubMed ID: 436304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of norethindrone oenanthate in 5 women after a single dose of norethindrone oenanthate and estradiol valerate.
    Sang GW; Liu XH
    Zhongguo Yao Li Xue Bao; 1986 May; 7(3):255-9. PubMed ID: 2954375
    [No Abstract]   [Full Text] [Related]  

  • 5. Triphasic pills: variability of endocrine parameters and of sex steroid-binding globulins.
    Pasinetti E; Falsetti L
    Acta Eur Fertil; 1993; 24(2):67-70. PubMed ID: 8171924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sex hormone binding globulin: effect of synthetic steroids on the assay and effect of oral contraceptives.
    Bowles SM; Mills RJ
    Ann Clin Biochem; 1981 Jul; 18(Pt 4):226-31. PubMed ID: 7197136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of zonisamide on the pharmacokinetics and pharmacodynamics of a combination ethinyl estradiol-norethindrone oral contraceptive in healthy women.
    Griffith SG; Dai Y
    Clin Ther; 2004 Dec; 26(12):2056-65. PubMed ID: 15823769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Control of fertility with oral medication.
    Diddle AW; Watts GF; Gardner WH; Williamson PJ
    West J Surg Obstet Gynecol; 1964; 72():222-9. PubMed ID: 12305556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioavailability of norethindrone in human subjects.
    Okerholm RA; Peterson FE; Keeley FJ; Smith TC; Glazko AJ
    Eur J Clin Pharmacol; 1978 Mar; 13(1):35-9. PubMed ID: 639831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radioimmunoassay of norethindrone : serum levels of norethindrone in lactating women after insertion of a single Silastic implant releasing norethindrone acetate.
    Laumas V; Malik BK; Jamal K; Seth U; Agarwal N; Hingorani V; Laumas KR
    Contraception; 1978 Dec; 18(6):593-605. PubMed ID: 750187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Existence of multiple peaks in plasma ethinyl estradiol and norethindrone after oral administration of a contraceptive pill.
    Zacur HA; Burkman RT; Kimball AW; Kwiterovich P; Bell WR
    J Clin Endocrinol Metab; 1992 Nov; 75(5):1268-72. PubMed ID: 1430087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radioimmunoassay of serum norethisterone oenanthate levels in women after intramuscular administration.
    Saxena BN; Shrimanker K; Fotherby K
    J Steroid Biochem; 1977 Oct; 8(10):1117-9. PubMed ID: 916668
    [No Abstract]   [Full Text] [Related]  

  • 13. The effect of etoricoxib on the pharmacokinetics of oral contraceptives in healthy participants.
    Schwartz J; Hunt T; Smith WB; Wong P; Larson P; Crumley T; Mehta A; Gottesdiener K; Agrawal N
    J Clin Pharmacol; 2009 Jul; 49(7):807-15. PubMed ID: 19443681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of a low-dose oral contraceptive on serum testosterone levels in polycystic ovary disease.
    Talbert LM; Sloan C
    Obstet Gynecol; 1979 Jun; 53(6):694-7. PubMed ID: 572024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subcutaneous bioabsorbable pellets of norethindrone for contraception in women: Phase I. Clinical study.
    Gupta GN; Saxena BB; Landesman R; Ledger WJ
    Fertil Steril; 1984 May; 41(5):726-31. PubMed ID: 6714449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolism of oral contraceptive drugs. The formation and disappearance of metabolites of norethindrone and mestranol after intravenous and oral administration.
    Mills TM; Lin TJ; Braselton WE; Ellegood JO; Mahesh VB
    Am J Obstet Gynecol; 1976 Dec; 126(8):987-92. PubMed ID: 998688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral contraceptives and sex hormone binding globulin capacity.
    Masurkar KG; Joshi UM
    Indian J Med Res; 1980 Feb; 71():221-4. PubMed ID: 7189743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Normalization of testosterone levels using a low estrogen-containing oral contraceptive in women with polycystic ovary syndrome.
    Raj SG; Raj MH; Talbert LM; Sloan CS; Hicks B
    Obstet Gynecol; 1982 Jul; 60(1):15-9. PubMed ID: 7201126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The interaction between St John's wort and an oral contraceptive.
    Hall SD; Wang Z; Huang SM; Hamman MA; Vasavada N; Adigun AQ; Hilligoss JK; Miller M; Gorski JC
    Clin Pharmacol Ther; 2003 Dec; 74(6):525-35. PubMed ID: 14663455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Radioimmunological study of the effect of hormonal contraceptives upon the progesterone level of saliva (author's transl)].
    Arnold M; Tóth I; Faredin I
    Zahn Mund Kieferheilkd Zentralbl; 1980; 68(7):713-8. PubMed ID: 6163264
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.